ArticleCold Spring Harbor molecular case studies2022

Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.

Christiane Wiedemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.